国产在线拍偷自揄拍无码,欧美成人精品高清在线观看,又粗又黄又爽视频免费看,亚洲精品一区二区久久

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

色妞ww精品视频7777| 欧美一区二区三区激情| 亚洲熟妇av一区二区三区漫画| 精品国产一区二区三区久久久狼| 精品久久久久久中文字幕大豆网| 亚洲精品一区国产欧美| 无码AV免费一区二区三区试看 | 久久久久亚洲av片无码下载蜜桃| 99久久无码一区人妻a片| 人人妻人人澡人人爽欧美一区| 色翁荡熄又大又硬又粗又视频| 国产成人一区二区三区| 日韩AV人人夜夜澡人人爽| VIDEOS丰满欧美熟妇| 欧美性生交xxxxx久久久| 久久96国产精品久久久| 欧美乱妇狂野欧美在线视频| 无码视频一区二区三区在线观看| 粗了大了 整进去好爽视频| 亚洲av久久无码精品九九| 日日天干夜夜狠狠爱| 久久精品国产| 欧美a级suv大全| 精品少妇人妻av一区二区三区 | 少妇大叫太大太粗太爽了a片小说| 久久精品国产大片免费观看 | 亚洲欧好州第一的日产suv| 野花日本大全免费观看3中文版| 国产亚洲AV无码AV男人的天堂| 老熟妇性色老熟妇性| 性欧美大战久久久久久久 | 国产av无码专区亚洲精品 | 女学生sm开腿调教娇喘视频| 久久精品亚洲中文字幕无码网站| 久久亚洲国产成人精品无码区| 无码专区丰满人妻斩六十路 | 亚洲AV区无码字幕中文色| 国产猛男猛女超爽免费视频 | 色欲人妻aaaaaaa无码| 国产伦精品一区二区三区不卡| 男人呻吟双腿大开男男h|